Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mingxiao Fang"'
Autor:
Jun Zheng, Ju Huang, Liang Zhang, Mengna Wang, Lihong Xu, Xiaoyun Dou, Xiaojing Leng, Mingxiao Fang, Yang Sun, Zhigang Wang
Publikováno v:
Biomaterials Research, Vol 27, Iss 1, Pp 1-22 (2023)
Abstract Background Although programmed cell death protein 1 (PD-1)/ programmed cell death-ligand protein 1 (PD-L1) checkpoint blockade immunotherapy demonstrates great promise in cancer treatment, poor infiltration of T cells resulted from tumor imm
Externí odkaz:
https://doaj.org/article/d7f0490c6ae5406d9086bab6828c1c87
Autor:
Ju Huang, Xiaojing Leng, Tao Jiang, Lihong Xu, Jun Zheng, Mingxiao Fang, Jingxue Wang, Zhigang Wang, Liang Zhang
Publikováno v:
Materials Today Bio, Vol 19, Iss , Pp 100555- (2023)
Immunotherapy shows great promise on treating tumors. However, insufficient antigen exposure and immunosuppressive tumor microenvironment (TME) caused by hypoxia impose a serial of constraints on the therapeutic efficacy. In this study, we developed
Externí odkaz:
https://doaj.org/article/c7187cc7f5ec47eba331d9b9ba3b4044
Autor:
Jun Zheng, Ju Huang, Liang Zhang, Mengna Wang, Lihong Xu, Xiaoyun Dou, Xiaojing Leng, Mingxiao Fang, Yang Sun, Zhigang Wang
Background Although programmed cell death protein 1 (PD-1)/ programmed cell death-ligand protein 1 (PD-L1) checkpoint blockade immunotherapy demonstrates great promise in cancer treatment, poor infiltration of T cells resulted from tumor immunosuppre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eb11ea6d49e38c473a62ffa941a3801
https://doi.org/10.21203/rs.3.rs-2149010/v1
https://doi.org/10.21203/rs.3.rs-2149010/v1
